FGFR3 mutations in non-muscle invasive bladder cancer: Prevalence and association with outcome - results of the epicuro study

被引：0
|
作者：
Hernandez-Llodra, Silvia
Lopez-Knowles, Elena
Lloreta, Josep
Kogevinas, Manolis
Amoros, Alex
Tardon, Adonina
Serra, Consol
Garcia-Closas, Reina
Carrato, Alfredo
Malats, Nuria
Real, Francisco X.
机构：
[1] Univ Pompeu Fabra, Barcelona, Spain
[2] IMIM, Barcelona, Spain
[3] Hosp del Mar, Barcelona, Spain
[4] Univ Oviedo, Oviedo, Spain
[5] Hosp Univ Tenerife, Tenerife, Spain
[6] Hosp Univ Elche, Elche, Spain
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4521
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immunotherapy for non-muscle invasive bladder cancer
    Cathomas, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 17 - 17
  • [22] IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Black, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 37 - 37
  • [23] Diagnosis of Non-Muscle Invasive Bladder Cancer
    Palou, Joan
    Boehle, Andreas
    Witjes, J. Alfred
    Colombel, Marc
    Brausi, Maurizio
    Lamm, Donald
    Persad, Raj
    Buckley, Roger
    Akaza, Hideyuki
    Soloway, Mark
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (10) : 627 - 636
  • [24] Intravesical BCG instillation for non-muscle invasive bladder cancer: Prevalence of adverse effects & association with efficacy
    Udovicich, C.
    Nankivell, P.
    Barberi, A.
    Page, D.
    Jenkins, M.
    Goad, J.
    Clarke, A.
    Niall, O.
    Temelcos, C.
    Cleeve, L.
    Wong, L-M.
    BJU INTERNATIONAL, 2015, 115 : 106 - 107
  • [25] FGFR3 MUTATIONS AND THEIR RELATION TO FGFR3 EXPRESSION AND CLINICAL OUTCOME IN A LARGE RADICAL CYSTECTOMY COHORT: IMPLICATIONS FOR ANTI-FGFR3 BLADDER CANCER TREATMENT?
    van Rhijn, Bas
    Mertens, Laura
    Mayr, Roman
    Bostrom, Peter
    Marquez, Mirari
    Zwarthoff, Ellen
    Boormans, Joost
    Abas, Cheno
    van Leenders, Geert
    Gotz, Stefanie
    Bertz, Simone
    Neuzillet, Yann
    Sanders, Joyce
    Broeks, Annegien
    van der Heijden, Michiel
    Jewett, Michael
    Real, Francisco
    Stohr, Robert
    Zlotta, Alexandre
    Eckstein, Markus
    Scoorojebally, Yanish
    Burger, Max
    Otto, Wolfgang
    Radvanyi, Francois
    Sirab, Nanour
    Pouessel, Damien
    van der Kwast, Theo
    Malats, Nuria
    Hartmann, Arndt
    Allory, Yves
    van der Schoot, Deric
    Zuiverloon, Tahlita
    JOURNAL OF UROLOGY, 2019, 201 (04): : E924 - E924
  • [26] COMUTATIONAL PATTERNS IN FGFR3-ALTERED NON-MUSCLE INVASIVE BLADDER CANCER INFLUENCE RECURRENCE AND PROGRESSION
    Neeta, D'Souza
    De Jesus, Escano Manuel
    Muneeb, Alam Syed
    Gao Sizhi
    Tang Xinran
    Alvin, Goh
    Bernard H, Bochner
    David, Solit
    Gopakumar, Iyer
    Hikmat, Al-Ahmadie
    Eugene, Pietzak
    Priya, Dave
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S55 - S55
  • [27] Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer
    C Blick
    A Ramachandran
    S Wigfield
    R McCormick
    A Jubb
    F M Buffa
    H Turley
    M A Knowles
    D Cranston
    J Catto
    A L Harris
    British Journal of Cancer, 2013, 109 : 50 - 59
  • [28] Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer
    Blick, C.
    Ramachandran, A.
    Wigfield, S.
    McCormick, R.
    Jubb, A.
    Buffa, F. M.
    Turley, H.
    Knowles, M. A.
    Cranston, D.
    Catto, J.
    Harris, A. L.
    BRITISH JOURNAL OF CANCER, 2013, 109 (01) : 50 - 59
  • [29] Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
    Hernandez, Silvia
    Lopez-Knowles, Elena
    Lloreta, Josep
    Kogevinas, Manolis
    Amoros, Alex
    Tardon, Adonina
    Carrato, Alfredo
    Serra, Consol
    Malats, Nuria
    Real, Francisco X.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3664 - 3671
  • [30] The long term outcome of high risk non-muscle invasive bladder cancer
    Thomas, F.
    Rubin, N.
    Goepel, J.
    Abbod, M. F.
    Rosario, D.
    Catto, J. W. F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E965 - U26
12345